logo
No longer in the running to head NASA, Jared Isaacman turns focus to private space missions

No longer in the running to head NASA, Jared Isaacman turns focus to private space missions

Yahoo5 days ago
Jared Isaacman may no longer have a shot at leading NASA, but that doesn't mean the billionaire and private astronaut is done with space.
In one of his first public appearances since President Donald Trump withdrew his nomination for him to be NASA administrator, Isaacman indicated he still has an interest in facilitating private spaceflight missions. The billionaire, who has been to space twice in two previous missions jointly funded with SpaceX, also hasn't ruled out making another cosmic venture now that he'll have more free time on his hands.
Isaacman's recent comments came June 21 after he received the National Space Society's Wernher von Braun Award for Polaris Dawn, the private astronaut mission he commanded in September 2024, SpaceNews.com reported. After a prepared speech, Isaacman also spoke of what his priorities would have been had he been confirmed as NASA administrator.
Here's what Isaacman recently discussed, as well as what to know about the billionaire spaceflight enthusiast.
In comments after a speech at the National Space Society's conference, Isaacman reportedly indicated his interest in exploring space outside of the agency, according to SpaceNews.
Isaacman's comments come at a difficult time for NASA − the agency faces steep budget cuts that can put several exploration missions at risk. Isaacman said in June that as NASA administrator, he would have sought partnerships with academic institutions that would have given such organizations a bigger role in funding.
Rather than focusing on human spaceflights missions, Isaacman suggested he's more interested now in bankrolling uncrewed robotic missions.
Isaacman's Polaris Dawn mission was intended to be the first of three missions he planned to fund under the Polaris Program. While he set those missions aside when he was nominated to lead NASA, it's unclear just when, or if, he'll pick them back up.
But in previous comments on social media, Isaacmen left the door open to going to space again.
"I have not flown my last mission," Isaacman said in a post May 31 on social media site X after Trump pulled his nomination to head NASA. "Whatever form that may ultimately take – but I remain incredibly optimistic that humanity's greatest spacefaring days lie ahead."
Isaacman, founder of payment processing company Shift4 Payments, has been to space twice under his private spaceflight venture known as the Polaris Program.
The most recent expedition drew plenty of headlines in September 2024 when Isaacman flew with an all-civilian crew of amateur spacefarers on a mission he jointly funded with Elon Musk's SpaceX.
During the mission, known as Polaris Dawn, the four-member crew ascended to 870 miles above Earth's surface – higher than any crewed vehicle has traveled since NASA's Apollo era ended in the 1970s. Two days into the mission, they became the first non-government astronauts to complete a spacewalk when both Isaacman and crew member Sarah Gillis exited the Dragon capsule separately for about 10 minutes each to take in the endless black expanse of outer space.
Isaacman's first trip to space came when he commanded the first all-civilian space crew in 2021 aboard a SpaceX capsule as part of a mission known as Inspiration4. Netflix filmed a documentary about the Inspiration4 mission.
By that time, space tourists had already begun taking short trips to the edge of space with companies like Richard Branson's Virgin Galactic and Jeff Bezos' Blue Origin. But Inspiration4 became known as the world's first all-civilian extended mission to space, with Isaacman, who funded the spaceflight, and three others spending three days living in orbit and conducting research.
Isaacman's nomination to lead NASA was well-received by most of the space community and members of Congress.
But at a critical time when the U.S. space agency is preparing to return humans to the moon and send the first astronauts to Mars, Trump suddenly pulled Isaacman's bid in late May. The decision came after Isaacman had cleared the Senate Commerce Committee in April and appeared on track for a full Senate vote.
Though Trump never offered a concrete reason for the about-face, Isaacman faced some pushback in the Senate for his close ties to Musk at a time when the SpaceX founder was on his way out of the White House. Other reports have suggested Isaacman's past donations to Democrats may have influenced Trumps decision, who said in a statement that "the next leader of NASA is in complete alignment with President Trump's America First agenda."
Trump, who said on Truth Social that he will propose a new nominee, first announced Isaacman's nomination in a December 2024 post, saying, 'Jared will drive NASA's mission of discovery and inspiration, paving the way for groundbreaking achievements in space science, technology, and exploration.'
NASA has now lacked a full-time administrator since Bill Nelson stepped down on Jan. 20, the day of Trump's inauguration.
Contributing: Joey Garrison, USA TODAY; Brooke Edwards, FLORIDA TODAY
Eric Lagatta is the Space Connect reporter for the USA TODAY Network. Reach him at elagatta@gannett.com
This article originally appeared on Florida Today: After Trump pulls Isaacman NASA bid, billionaire eyes next space mission
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

DOGE sprouts in red states, as governors embrace the cost-cutter brand and make it their own
DOGE sprouts in red states, as governors embrace the cost-cutter brand and make it their own

Washington Post

time14 minutes ago

  • Washington Post

DOGE sprouts in red states, as governors embrace the cost-cutter brand and make it their own

HARRISBURG, Pa. — The brash and chaotic first days of President Donald Trump 's Department of Government Efficiency, once led by the world's richest man Elon Musk , spawned state-level DOGE mimicry as Republican governors and lawmakers aim to show they are in step with their party's leader. Governors have always made political hay out of slashing waste or taming bureaucracy, but DOGE has, in some ways, raised the stakes for them to show that they are zealously committed to cutting costs. Many drive home the point that they have always been focused on cutting government, even if they're not conducting mass layoffs .

After Saving $1.3 Million At 35, This Doctor Wonders If It's Finally Lamborghini Time
After Saving $1.3 Million At 35, This Doctor Wonders If It's Finally Lamborghini Time

Yahoo

time26 minutes ago

  • Yahoo

After Saving $1.3 Million At 35, This Doctor Wonders If It's Finally Lamborghini Time

A 35-year-old physician earning $350,000 a year has saved $1.3 million and is now wondering if it's time to stop playing it so safe and finally splurge on the dream car he's always wanted: a Lamborghini. 'I don't want to look back and think, 'I wish I had spent more and had fun when I was young,'' the doctor wrote in a popular Reddit post on r/whitecoatinvestor, a subreddit filled with financially savvy medical professionals. Don't Miss: Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die." $100k+ in investable assets? – no cost, no obligation. 'You want to blow 30-40% of what you made in a decade in a single afternoon?' one person asked bluntly. Another said, 'Lambo money is $1M a year or more. This is like a barista buying a Birkin bag.' Still, not everyone was against the idea. Many encouraged the physician to explore the fantasy without committing outright. One of the top responses suggested spending $1,000 or $2,000 to test drive a variety of exotic cars. 'Try them all at 150 mph and see if that's enough for you,' the commenter said. Others recommended a more practical splurge. 'A really high-end car will turn heads but it comes at like a $150K premium to something you can use that will also turn heads and drive to what is your likely capability,' one commenter said, suggesting a Porsche 911 or BMW M4 as middle-ground options. Trending: The secret weapon in billionaire investor portfolios that you almost certainly don't own yet. Plenty of people pointed out that while $1.3 million is an impressive savings milestone, it may not justify a purchase as extravagant as a Lamborghini. One financial planner shared that a client with $2.5 million in investments still struggled with the idea of splurging. 'She ended up settling on a trip of a lifetime. We still talk about it to this day.' 'If you worked hard your entire life with the explicit purpose to buy a Lambo, then maybe you should do it,' another person said. 'However, I like cars quite a bit but would still never spend that much at that net worth.' A few were more philosophical. 'Sometimes it's not about generational wealth or even wealth beyond need. Sometimes it's just life. You really only do live once. Let no one influence your enjoyment of such.'Even those supportive of the idea urged the doctor not to buy new. 'Buy a used Huracan for $200K. The first owner took the depreciation hit. Keep it a couple years and resell for $180K,' one user advised. 'Costs you $20K in depreciation vs $100K in depreciation.' And then there were the skeptics who had been there and done that. One Porsche owner said his 911 mostly sat in the garage and was eventually sold. 'I loved my Toyota Tundra so much, the Porsche sat in the garage for six years and only got 20K miles.' Ultimately, the community's message boiled down to this: Don't let fear of missing out or burnout push you into a massive decision. Rent first, try it out, and if you love it, go for it. Just don't expect the Lambo to solve anything deeper. Read Next: Over the last five years, the price of gold has increased by approximately 83% — Investors like Bill O'Reilly and Rudy Giuliani are using this platform to UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? APPLE (AAPL): Free Stock Analysis Report TESLA (TSLA): Free Stock Analysis Report This article After Saving $1.3 Million At 35, This Doctor Wonders If It's Finally Lamborghini Time originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved.

Regeneron (REGN) Scores FDA Approval, JP Morgan Reaffirms $800 Price Target
Regeneron (REGN) Scores FDA Approval, JP Morgan Reaffirms $800 Price Target

Yahoo

time26 minutes ago

  • Yahoo

Regeneron (REGN) Scores FDA Approval, JP Morgan Reaffirms $800 Price Target

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) is one of the 11 best debt-free stocks to invest in right now. The company secured accelerated FDA approval for Lynozyfic (linvoseltamab-gcpt) on July 2, 2025, marking a significant progress in the treatment of relapsed or refractory multiple myeloma in patients who have undergone four or more prior therapies. The approval adds depth to the company's late-stage pipeline. Moreover, it enhances the company's long-term growth trajectory in a high-need, underserved segment of the cancer market. A medical professional holding vials of biotechnology therapeutic candidate. On the other side, on July 7, JP Morgan analyst Chris Schott reiterated a Buy rating on Regeneron, while maintaining his $800 price target. Although Regeneron has faced recent headwinds, particularly around Eylea, Schott expects those pressures to ease. He points to patient affordability issues and competitive dynamics as near-term hurdles, but believes the enhanced Eylea HD formulation and expanded copay assistance programs should help stabilize sales. Offsetting some of this softness is the continued strength of Dupixent, which Schott sees as a key growth engine, especially as new indications expand its market reach. Looking ahead, Schott views the setup for Regeneron shares as compelling. With a strong balance sheet and growing contributions from Dupixent, he sees room for upside even without relying on near-term pipeline catalysts. However, potential updates, including LAG-3 data in melanoma and further clarity on Eylea, could serve as meaningful valuation drivers. Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) is a biotechnology company focused on discovering, developing, and distributing innovative therapies that address serious and life-threatening diseases. While we acknowledge the potential of REGN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: Harvard University Stock Portfolio: Top 10 Stock Picks and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store